Filing Details
- Accession Number:
- 0000899243-16-015092
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-03-02 21:02:12
- Reporting Period:
- 2016-02-29
- Filing Date:
- 2016-03-02
- Accepted Time:
- 2016-03-02 21:02:12
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1594864 | Juno Therapeutics Inc. | JUNO | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1480212 | Edgar Hans Bishop | C/O 307 Westlake Avenue North, Suite 300 Seattle WA 98109 | See Remarks | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-02-29 | 54,000 | $6.36 | 2,741,359 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2016-02-29 | 86,871 | $35.27 | 2,654,488 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2016-02-29 | 3,879 | $36.46 | 2,650,609 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2016-02-29 | 54,000 | $0.00 | 54,000 | $6.36 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 893,506 | 2024-09-08 | No | 4 | M | Direct |
Footnotes
- 1/48 of the shares subject to the option became vested and exercisable on October 9, 2014 and 1/48th of the shares subject to the option vested monthly thereafter.
- This transaction was executed in multiple trades at prices ranging from $34.78 to $35.76. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $35.90 to $36.68. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 22, 2014, as amended March 20, 2015.
Billionaire Hedge Funds
